Matinas BioPharma Holdings, Inc. (MTNB): Revenue
Older than the company's other figures. The latest Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$1.10M
Year ended 2023-12-31
+90.6%
3-year compound annual growth
+55.7%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $1.10M | -65.6% | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | $3.19M | n/m | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $33.0K | -79.2% | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | $158.3K | +76.3% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $89.8K | -25.0% | 2021-03-29, From 2019-01-01 |
| 2018-12-31 | $119.8K | -20.0% | 2020-03-09, From 2018-01-01 |
| 2017-12-31 | $149.7K | n/a | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | $0 | -100.0% | 2017-03-31, From 2016-01-01 |
| 2015-12-31 | $194.5K | n/a | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | $0 | n/a | 2016-03-30, From 2014-01-01 |